NIH Official Discusses Need To Issue Exclusive License To Drug Company For Zika Vaccine Development With U.S. House, Senate Staff

CQ HealthBeat: NIH Tries to Ease Concerns About Zika Vaccine Deal
“The federal government is considering granting a pharmaceutical company an exclusive license to further develop a taxpayer-funded vaccine for the Zika virus, just weeks after a similar arrangement was scuttled following blowback from health groups and lawmakers. … In a pair of conference calls with House and Senate staff members, [NIAID Director Anthony] Fauci made a case for why the government needs industry partners to get a Zika vaccine to market…” (Siddons, 10/16).